Martin D. Madaus
Sits on 5 boards. Overboarded · 5 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 5
- Current seats
- 5
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 5 boards, counting each seat separately. Longest: Quanterix Corporation, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Azenta Inc. January 28, 202687.2%
-
Azenta Inc. January 30, 202585.7%
-
Quanterix Corporation June 3, 202449.9%
-
Azenta Inc. January 30, 202494.2%
-
Standard BioTools Inc. June 14, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 22, 2026 | Azenta Inc. | Shares withheld for tax | −1,294 | $36.01 | $46,597 |
| Sep 22, 2026 | Azenta Inc. | Shares withheld for tax | −1,456 | $34.28 | $49,912 |
| Sep 14, 2026 | Azenta Inc. | Grant or award | +36,653 | — | — |
| Jul 24, 2026 | Haemonetics Corporation | Grant or award | +2,538 | — | — |
| May 14, 2026 | Repligen Corporation | Grant or award | +995 | — | — |
| Aug 8, 2025 | Repligen Corporation | Open-market purchase | +1,800 | $112.13 | $201,834 |
| May 15, 2025 | Repligen Corporation | Grant or award | +973 | — | — |
| Jan 2, 2025 | Quanterix Corporation | Grant or award | +7,435 | — | — |
| Nov 19, 2024 | Azenta Inc. | Open-market purchase | +4,940 | $40.77 | $201,404 |
| Jun 14, 2024 | Repligen Corporation | Open-market purchase | +915 | $124.54 | $113,954 |
| Jun 14, 2024 | Repligen Corporation | Open-market purchase | +700 | $125.46 | $87,822 |
| May 16, 2024 | Repligen Corporation | Grant or award | +701 | — | — |
| Feb 12, 2024 | Azenta Inc. | Grant or award | +2,465 | $65.93 | $162,517 |
| Jan 2, 2024 | Quanterix Corporation | Grant or award | +2,947 | — | — |
| Oct 20, 2023 | Standard BioTools Inc. | Grant or award | +1,574 | $2.54 | $3,998 |
Questions about Martin D. Madaus
What boards is Martin D. Madaus on?
Martin D. Madaus sits on the boards of Azenta Inc., Haemonetics Corporation, Quanterix Corporation, Repligen Corporation and Standard BioTools Inc.
How long has Martin D. Madaus served on boards?
Our records show at least 14 years of board service across 5 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.